GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Virbac SA (FRA:V16) » Definitions » Ending Cash Position

Virbac (FRA:V16) Ending Cash Position : €173 Mil (As of Dec. 2023)


View and export this data going back to 2012. Start your Free Trial

What is Virbac Ending Cash Position?

Virbac's Ending Cash Position for the quarter that ended in Dec. 2023 was €173 Mil.

Virbac's quarterly Ending Cash Position increased from Dec. 2022 (€177 Mil) to Jun. 2023 (€203 Mil) but then declined from Jun. 2023 (€203 Mil) to Dec. 2023 (€173 Mil).

Virbac's annual Ending Cash Position increased from Dec. 2021 (€172 Mil) to Dec. 2022 (€177 Mil) but then declined from Dec. 2022 (€177 Mil) to Dec. 2023 (€173 Mil).


Virbac Ending Cash Position Historical Data

The historical data trend for Virbac's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Virbac Ending Cash Position Chart

Virbac Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79.85 179.57 172.14 176.68 173.36

Virbac Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.14 159.01 176.68 203.18 173.36

Virbac Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Virbac's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=184.654+-11.296
=173

Virbac's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=205.909+-32.551
=173


Virbac Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Virbac's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Virbac (FRA:V16) Business Description

Traded in Other Exchanges
Address
2065m LID, 1 ere avenue, Carros, FRA, 06516
Virbac SA is a drug manufacturing company with a focus on animal health. The company generates the vast majority of its revenue in Europe, followed by North America and Latin America.

Virbac (FRA:V16) Headlines

No Headlines